RoodMicrotec: Annual figures for 2014

Zwolle, 30 April 2015 2004 HIGHLIGHTS Commercial/operational * Sales in 2014 of EUR 9.971 million fell by 11% compared to 2013 (EUR 11.180 million) due to longer lead times and postponement of some large orders. Decline mainly in Test, Test Engineering and Qualification & Reliability. * Lower sales and seizing new market opportunities have resulted in a net result of EUR 1.693 million negative in 2014 (2013: EUR 0.284 million negative)...
New York, (informazione.it - comunicati stampa - elettronica)

Zwolle, 30 April 2015

 

2004 HIGHLIGHTS

Commercial/operational

  • Sales in 2014 of EUR 9.971 million fell by 11% compared to 2013 (EUR 11.180 million) due to longer lead times and postponement of some large orders. Decline mainly in Test, Test Engineering and Qualification & Reliability.
  • Lower sales and seizing new market opportunities have resulted in a net result of EUR 1.693 million negative in 2014 (2013: EUR 0.284 million negative).
  • Increased investments in the second half of 2014 in sales and marketing.
  • Setup of Automotive Competitive Centre and investments in automotive infrastructure as a result of new automotive projects and new prospects.
  • Investments in highly promising projects like 'light switches based on radiofrequency'.
  • Strategic partnership with Fraunhofer Institute IIS.
  • Further strengthening of SCM.
  • New test handling and programming equipment to handle new promising products of (new) customers.
  • Sharp increase of our quote portfolio and a continued positive book-to-bill ratio.
  • Significant headcount cost reduction program resulting in EUR 1.300 million within the next three years. This program is partly based on attrition, but also on forced layoffs.
  • The difference in personnel costs compared to 2013 was caused mainly by a non-recurring income in respect of the pension scheme.
  • Strategic adjustment in response to changing market conditions. Our new approach involves longer lead times.

 

Financials

 

 

  • EBITDA: EUR 0.722 million negative (2013: EUR 0.870 million positive).
  • EBIT (operating result) was EUR 1.514 million negative (2013: EUR 0.13 million negative).
  • Net result of EUR 1.693 million negative (2013: EUR 0.284 million negative). At year-end 2014 the company had approximately EUR 15 million in accumulated tax losses which can be offset against future tax profits for an indefinite period of time. In other words, the company's tax loss carry forward potential is around EUR 15 million. However, the company takes a conservative approach on this and only recognised EUR 1.6 million as deferred tax asset.
  • Net cash position improved from EUR 1.326 million negative in 2013 to EUR 0.192 million positive in 2014. The net cash from operating activities were EUR 0.262 million negative in 2014 compared to EUR 0.017 million positive in 2013.
  • The working capital position improved strongly from EUR 1.331 million negative in 2013 to EUR 0.125 million negative in 2014.
  • Decrease in solvency rate to 27% (2013: 39%) as a result of the net loss and the decrease of the pension discount rate from 3.6% to 2%. (This discount rate change in had a negative impact on the equity position of EUR 1.0 million).
  • Issue of EUR 2.500 million bond loan and repayment of bank loans. All short-term loans, except for the finance lease, were redeemed using the proceeds from the bond loan. This form of financing has greatly reduced RoodMicrotec's finance liabilities for the short term.

 

KEY FIGURES

 

31 December 2014

 

 

 

 

 

(X EUR 1,000)

IFRS

IFRS

IFRS

IFRS

IFRS

 

2014

2013

2012

2011

2010

 

 

restated

restated

 

 

Result

 

 

 

 

 

 

 

 

 

 

 

Net sales

9,971

11,180

11,971

15,717

15,563

Gross margin

8,184

9,021

9,688

12,342

12,242

EBITDA

-722

870

703

1,865

2,361

EBIT (operating result)

-1,514

-13

-181

709

733

EBT

-1,675

-243

-507

408

207

Cash flow (net result and depreciation)

-901

599

603

1,744

2,076

Cash flow from operating activities

-262

17

899

1,939

1,689

Net result

-1,693

-284

-281

588

448

 

 

 

 

 

 

 

 

 

 

 

 

Capital, debt & liquidity ratios

 

 

 

 

 

Total assets

 13,617

13,941

12,915

12,857

13,726

Group equity

3,706

5,396

 5,457

6,139

5,647

Net debt

2,159

2,113

3,216

2,686

3,334

Capital (net debt  + equity)

5,865

7,509

8,673

8,824

8,981

Gearing ratio (net debt/ capital)

37%

28%

37%

30%

37%

Solvency (group equity / total liabilities)

27%

39%

42%

48%

41%

Debt ratio (net debt / EBITDA)

-2.99

2.43

4.57

1.44

1.41

Net working capital

-125

-1.331

-1.422

-831

-569

Working capital ratio

0.95

0.68

0.63

0.79

0.87

 

 

 

 

 

 

Assets

 

 

 

 

 

Tangible fixed assets

5,567

5,446

6,347

5,732

5,710

Investments in tangible fixed assets

499

535

1,475

1,024

681

Depreciation of tangible fixed assets

792

869

860

1,156

1,600

 

 

 

 

 

 

Data per share (x EUR 1)

 

 

 

 

 

Capital and reserves

0.09

0.14

0.15

0.17

0.16

Operating results

-0.03

0.00

-0.01

0.02

0.02

Cash flow

-0.00

0.00

0.03

0.05

0.05

Net result

-0.03

-0.01

-0.01

0.02

0.01

Share price: year-end

0.25

0.16

0.15

0.16

0.17

Share price: highest

0.35

0.18

0.23

0.31

0.19

Share price: lowest

0.15

0.14

0.15

0.14

0.15

 

 

 

 

 

 

Issue of nominal shares

 

 

 

 

 

At year-end (x 1,000)

43,519

38,674

35,769

35,769

35,769

 

 

 

 

 

 

Number of FTEs (permanent)

 

 

 

 

 

At year-end

94

96

103

106

120

Average

97

 99

103

111

124

 

 

 

 

 

 

Sales (total) / average FTEs (permanent)

103

113

116

142

126

 

 


Audited financial statements 2014

On 12 March 2015 we published our preliminary financial figures. Following the completion of the audit, certain adjustments were made. The most important ones related to the financial assets, pension obligations and to the financial results, which we summarise below. The adjustments do not have a material effect on the operational cash flow.

The total assets were EUR 13.617 million, which is EUR 2.447 million higher than presented before. The increase is mainly due to the reclassification of financial assets of EUR 2.494 million, which were previously presented under pension liabilities and the cash position. These items also led to a restatement of the comparative figures as per 1 January 2013 and 31 December 2013. The financial assets comprise bonds of EUR 2.494 million, which are held for financing pension liabilities and have been placed under a Contractual Trust Agreement. However, these bonds were not transferred to the Trustee as per 31 December 2014 and therefore may not be netted against the pension liabilities. As at 20 April 2015, these bonds were definitively transferred to the Trustee. As a result, the corresponding financial assets therefore may be netted against the pension liabilities in 2015.

EBIT for 2014 was EUR 1.514 million negative, which is EUR 178 thousand lower than presented in the preliminary figures. This was due to additional audit and legal fees of approx. EUR 70 thousand and additional cost accruals in personnel and other expenses of approx. EUR 108 thousand. Taxes through the profit and loss statement for 2014 were EUR 18 thousand negative, compared to  EUR 144 thousand positive as we stated in the preliminary figures.  This resulted into a negative effect of the profit and loss statement of EUR 162 thousand. The comparable figures of the profit and loss statement have been restated due to an adjustment in the pension costs of EUR 95 thousand.

Reference is made to the deferred tax assets and the valuation of the financial assets as explained in the Annual Report in note 10 and note 11 as well as the audit opinion on these items on page 117/118 of our Annual Report.

 

Trading update first quarter 2015

As the first quarter has since closed we will issue our trading update now.

In line with expectations, the first quarter of 2015 showed an improvement in operations, resulting in a higher sales compared to last year and over budget. The increase was limited, but compared to recent years it is a positive trend break. RoodMicrotec's management considers this a clear positive signal. 

As published before, we have more than 20 new projects on hand, for which we have high expectations for the near future. Of this new business with a volume of EUR 5 to 10 million per year as of 2015, 80-90% will come on top of our current business. This supports our projection that we will be able to achieve significant growth up to and including 2018. We are already invoicing for the start-up or investing in the preparation of more than 50% of these new projects. We are realising this new business in our core segments Automotive (50%) and  Industrial/Medical (30%), but also in high-end consumer business (20%). Automotive and Industrial/Medical are among the fastest growing segments in the market. This supports our expectation that we will grow significantly over the next few years.

This volume of new business is unparalleled, which gives the management of RoodMicrotec confidence that we are on the right way for a full recovery.

 

 

Conference call Friday 1 May 2015, 10:00 am

A conference call will be held for press, analysts and other interested parties on 1 May. The telephone number to join the call is  + 31 20 531 5854

 

Information meeting 13 May 2015 at 4 pm, Euronext Amsterdam, Beursplein 5

Investors, bondholders, analysts, journalists and other interested parties are invited to join the investors meeting on 13 May at 4 pm, in which we will give information concerning the business and will present our new CTO Martin Sallenhag.

 

Annual General Meeting of Shareholders 11 June 2015 at 2 pm, Euronext Amsterdam, Beursplein 5

The Annual General Meeting of Shareholders will be held on Thursday 11 June 2015.

 

 

Financial agenda

13 May 2015

Information meeting for investors, bondholders, analysts, journalists and other interested parties

11 June 2015

Annual general meeting of shareholders

9 July 2015

Publication sales figures first half 2015

27 August 2015

Publication interim report 2015

27 August 2015

Conference call for press and analysts

12 November 2015

Publication trading update

7 January 2016

Publication annual sales figures 2015

25 February 2016

Publication annual figures 2015

25 February 2016

Conference call for press and analysts

10 March 2016

Publication annual report 2015

21 April 2016

Annual general meeting of shareholders

12 May 2016

Publication trading update

7 July 2016

Publication sales figures first half 2016

25 August 2016

Publication interim report 2016

25 August 2016

Conference call for press and analysts

15 November 2016

Publication trading update


 

Consolidated statement of profit or loss

 

 

(x EUR 1,000)

 

Notes

 

2014

2013

restated*

 

 

 

 

Net sales

1

9,971

11,180

Cost of sales

2

-1,787

-2,159

Gross profit

 

8,184

9,021

 

 

 

 

Personnel expenses

3

-6,058

-5,446

Other operating expenses

4

-2,848

-2,705

Total operating expenses

 

-8,906

-8,151

 

 

 

 

EBITDA

 

-722

870

 

 

 

 

Depreciation and amortisation

5

-792

-883

EBIT

 

-1,514

-13

 

 

 

 

Financial expenses

6

-161

-230

Profit before tax

 

-1,675

-243

 

 

 

 

Taxation

7

-18

-41

Net profit (loss)

 

-1,693

-284

 

 

 

 

 

Net profit attributable to:

 

Owners of the company

 

-1,693

-284

Non-controlling interests

 

 

-

Net profit (loss)

 

-1,693

-284

 

Earnings per share

 

Basic

16

-0.04

-0.01

Diluted

16

-0.04

-0.01

 

 

* Certain amounts shown here do not correspond to the 2013 financial statements and reflect adjustments made, referring to prior period adjustments

 


Consolidated statement of financial position

 

 

(x EUR 1,000)

 

Notes

31-12-2014

31-12-2013

restated*

01-01-2013

restated*

 

 

 

 

 

Assets

 

 

 

 

 

 

 

 

 

Property, plant and equipment

8

5,567

5,446

6,347

Intangible assets

9

1,741

1,741

1,755

Deferred taxes

10

1,079

910

951

Financial assets

11

2,982

2,991

1,449

Non-current assets

 

11,369

11,088

10,502

 

 

 

 

 

Inventories

12

344

283

305

Trade and other receivables

13

1,712

2,359

2,089

Cash and cash equivalents

14

192

211

19

Current assets

 

2,248

2,853

2,413

 

 

 

 

 

Total assets

 

13,617

13,941

12,915

 

 

 

 

 

 

Equity and liabilities

 

 

 

 

 

 

 

 

 

Share capital

 

4,788

4,255

3,935

Share premium

 

18,084

17,851

17,751

Revaluation reserve

 

1,859

1,668

1,890

Net benefit reserve

 

-1,834

-880

-975

Retained earnings

 

-21,245

-19,992

-19,638

Mezzanine capital

 

2,494

2,494

2,494

Mezzanine capital loss participation

 

-440

-

-

Equity attributable to shareholders

15

3,706

5,396

5,457

 

 

 

 

 

Loans and borrowings

18

2,306

279

1,399

Retirement benefit obligation

19

5,232

4,082

2,224

Non-current liabilities

 

7,538

4,361

3,623

 

 

 

 

 

Bank overdraft

14

-

1,537

1,381

Loans and borrowings

18

45

508

455

Trade and other payables

20

2,270

2,081

1,977

Current tax liabilities

18

58

58

22

Current liabilities

 

2,373

4,184

3,835

 

 

 

 

 

Total equity and liabilities

 

13,617

13,941

12,915

 

* Certain amounts shown here do not correspond to the 2013 financial statements and reflect adjustments made, referring  to prior period adjustments

 


Consolidated cash flow statement

 

 

 

 

 

(x EUR 1,000)

 

Notes

 

2014

2013

restated*

 

 

 

 

EBITDA

 

-722

870

Adjustments for:

 

 

 

-  Movements in net defined benefit obligations

 

-103

-535

-  Share-based payments

17

59

20

-  Accrued interest

6

-

-9

Changes in working capital

 

 

 

-  Inventories

12

-61

22

-  Trade and other receivables

13

647

-270

-  Trade and other accrued liabilities

18,20

79

140

Cash generated from operating activities

 

-101

238

Interest paid

6

-161

-221

Net cash from operating activities

 

-262

17

 

 

 

 

Cash flows from investing activities

 

 

 

Acquisition of property, plant and equipment

8

-499

-535

Disposal of property, plant and equipment

8

-

567

Di-/investments in defined benefit plan

19

-

2,487

Net investments in financial assets

11

9

-1,542

Net cash from investing activities

 

-490

977

 

 

 

 

Cash flows from financing activities

 

 

 

Proceeds from issue of share capital

15

707

400

Payment of compensation mezzanine capital

15

-

-292

Proceeds from issuance of mezzanine capital

 

-

-

Proceeds from borrowings

 

2,550

50

Repayment of borrowings

 

-903

-1,116

Payment of bond issuance costs

18

-100

-

Amortization of discount and bond issuance costs

18

16

-

Net cash flow from financing activities

 

2,270

-958

 

 

 

 

Net cash flow

 

1,518

36

 

 

 

 

Cash -/- bank overdrafts at 1 January

14

-1,326

-1,362

Cash -/- bank overdrafts at 31 December

14

192

-1,326

Net cash flow

 

1,518

36

 

* Certain amounts shown here do not correspond to the 2013 financial statements and reflect adjustments made, referring to prior period adjustments

 

 

 

About RoodMicrotec

With 45 years' experience as an independent value-added service provider in the area of micro and optoelectronics, RoodMicrotec offers fabless companies, OEMs and other companies a one-stop shopping proposition. With its powerful solutions RoodMicrotec has built up a strong position in Europe.

 

Our services comply with the industrial and quality requirements of the high reliability/space, automotive, telecommunications, medical, IT and electronics sectors.

 

'Certified by RoodMicrotec' concerns inter alia testing of products to the stringent ISO/TS 16949 standard that applies to suppliers to the automotive industry. The company also has an accredited laboratory for test activities and calibration to the ISO/IEC 17025 standard.

 

The value-added services comprise inter alia (eXtended) supply chain management, failure & technology analysis, qualification & burn-in, test- & product engineering, production test (including device programming and end-of-line service), ESD/ESDFOS assessment & training, quality & reliability consulting and total manufacturing solutions with partners.

 

RoodMicrotec has branches in Germany (Dresden, Nördlingen, Stuttgart), the UK (Bath) and the Netherlands (Zwolle).

 

 

Further information:

Philip Nijenhuis, CEO

Telephone:        +31 (0)38 4215216

Email:              [email protected]

Website:           www.roodmicrotec.com


Copyright GlobeNewswire

Attachment(s)
http://hugin.info/130789/R/1917817/686166.pdf


This announcement is distributed by NASDAQ OMX Corporate Solutions on behalf of NASDAQ OMX Corporate Solutions clients.
The issuer of this announcement warrants that they are solely responsible for the content, accuracy and originality of the information contained therein.
Source: %s via Globenewswire


[HUG#1917817]
Per maggiori informazioni
Ufficio Stampa
 Thomson Reuters (Leggi tutti i comunicati)
3 Times Square
10036 New York, NY